PACS Group, Inc. (PACS): A Bull Case Theory 

We came across a bullish thesis on PACS Group, Inc. on wallstreetbets subreddit by Simple-Software3. In this article, we will summarize the bulls’ thesis on PACS. PACS Group, Inc.’s share was trading at $14.13 as of October 2nd. PACS’s trailing and forward P/E were 23.33 and 6.31 respectively according to Yahoo Finance.

PACS Group, Inc. (PACS) operates a network of skilled nursing and assisted living facilities across the U.S., currently managing 316 facilities with over 32,000 skilled nursing beds and 2,400 assisted living beds, serving nearly 30,000 patients daily. Demand for post-acute care is structurally supported by demographics, and the company maintains strong operational metrics, including 88.9% overall occupancy, with mature facilities at 95.1%, and a skilled services mix driving higher-margin revenue.

Approximately 65% of facilities hold 4- or 5-star CMS ratings, reflecting quality performance. Despite ongoing SEC filing delays, including Q3 2024, FY 2024 10-K, and early 2025 quarters, PACS has secured multiple NYSE extensions through November 19, 2025, indicating regulatory confidence in the company’s progress and underlying value.

Technical defaults triggered with lenders, including Truist Bank and Omega, were resolved through forbearance rather than enforced default, signaling lender recognition of the company’s long-term viability. PACS has strengthened its leadership and compliance team with the appointment of a returning interim CFO and an experienced interim Chief Compliance Officer, while cash balances increased to $294 million, providing ample liquidity for operations and growth. The company’s stock, trading near $12, remains significantly below analyst targets of $30+, reflecting mispricing due to past short-seller claims and filing delays rather than operational weakness.

Comparable peers, like $ENSG, trade substantially higher, underscoring PACS’s relative undervaluation. With filings expected to be cleared imminently, preliminary operating results strong, and strategic safeguards in place, PACS presents a high-upside opportunity for equity investors, with potential for re-rating to $20–30 per share or more as regulatory and market uncertainties are resolved. The ongoing operational momentum and structural demand drivers position PACS for sustained growth and value creation.

Previously we covered a bullish thesis on Tenet Healthcare Corporation (THC) by BlackSwanInvestor in December 2024, which highlighted efficient hospital and ambulatory care operations, strong cash flow, debt reduction, and high-margin growth in Ambulatory Care. The stock has appreciated approximately 61.79% since coverage as operational improvements played out. The thesis still stands. Simple-Software3 shares a similar perspective but emphasizes PACS Group’s structural demand, regulatory extensions, and operational resilience.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW 

Disclosure: None.